Construction and Validation of an Immune-Related Gene Prognostic Index for Esophageal Squamous Cell Carcinoma

Immune checkpoint inhibitor (ICI) therapy may benefit patients with advanced esophageal squamous cell carcinoma (ESCC); however, novel biomarkers are needed to help predict the response of patients to treatment. Differentially expressed immune-related genes within The Cancer Genome Atlas ESCC datase...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Qinghua, Cai, Yingying, Shrestha, Sachin Mulmi, Shen, Duo, Zhao, Wei, Shi, Ruihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553461/
https://www.ncbi.nlm.nih.gov/pubmed/34722771
http://dx.doi.org/10.1155/2021/7430315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553461/
https://www.ncbi.nlm.nih.gov/pubmed/34722771
http://dx.doi.org/10.1155/2021/7430315

Ejemplares similares